Startup 10x Science Secures $4.8M Seed Round to Address Drug Candidate Characterization Bottleneck
10x Science, a startup founded in December 2025, has raised $4.8 million in seed funding to address the challenge of characterizing AI-generated drug candidates. The company aims to streamline the process of measuring and analyzing potential biologic drugs using advanced techniques like mass spectrometry. The startup was founded by biochemists and AI experts with experience from Stanford's lab of Nobel laureate Dr. Carolyn Bertozzi.
Tickers: $MRK
Topics: AI in Science Biotech Startups Drug Development Mass Spectrometry Protein Structure Prediction